Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Pfizer’s RSV vaccine has struggled to compete with one from GSK in a market that now also includes Moderna. Bloomberg Intelligence analyst John Murphy called the earnings report “largely ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Moderna's stock fell more ... of Novavax and GSK both fell around 1%. Pfizer's stock fell almost 2%, even after the company ...

Sky News host Gabriella Power discusses the “plummet” in Pfizer and Moderna stocks following RFK Jr clearing a Senate vote ...

Pfizer makes the Comirnaty vaccine with German partner BioNTech ... is likely benefiting from brand loyalty versus competitor Moderna. Sales of its heart disease drug, sold as Vyndaqel and ...

But the bill also would prohibit mRNA vaccines, like those developed by Pfizer and Moderna to combat COVID-19, Shippy told ...